The dopamine genetic risk score, developed by the combination of gene polymorphisms implicated in dopamine neurotransmission including DAT, has been associated with the risk of depressive symptomatology in non-PD populations [60]. This evidence concerns the gene SLC6A3 and Parkinson disease.